Login to Your Account

Inspiration Teams with Celtic in $35M Hemophilia Deal

By Trista Morrison

Thursday, January 10, 2008
While ramping up to begin clinical trials with its recombinant Factor IX product for hemophilia B, Inspiration Biopharmaceuticals Inc. entered a $35 million collaboration with Celtic Pharmaceutical Holdings LP. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription